Two Sigma Advisers’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-153,000	Closed	-$363K	–	2688
2023 Q4	$363K	Buy	153,000 +46,000	+43%	+$109K	﹤0.01%	2043
2023 Q3	$150K	Buy	107,000 +89,600	+515%	+$125K	﹤0.01%	2148
2023 Q2	$52.7K	Buy	+17,400	New	+$52.7K	﹤0.01%	2272